Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bai Liu

The IL-15 Superagonist ALT-803 Enhances Anti-Cd20 Antibody-Directed NK Cell ADCC and in Vivo Clearance of B Cell Lymphomas

Journal for ImmunoTherapy of Cancer

English

Challenge or Opportunity of Climate Financial Fragmentation

International Journal of Climate Change Strategies and Management

English

Related publications

Combining ROR1- Specific Chimeric Antigen Receptor (CAR) NK Cells With IL-15 Superagonist (N-803/Alt-803) to Target Chemotherapy Resistant Neuroblastoma

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2019

English

Combining Dinutuximab With ALT-803 (IL-15 Superagonist) Significantly Improves the Activity of Ex Vivo Expanded Natural Killer Cells Against GD2 + Pediatric Solid Tumors (ST)

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2018

English

Elotuzumab Directly Enhances NK Cell Cytotoxicity Against Myeloma via CS1 Ligation: Evidence for Augmented NK Cell Function Complementing ADCC

Cancer Immunology, Immunotherapy

English

Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models

Cancer immunology research

Cancer Research

Immunology

2015

English

Adipocyte IL-15 Regulates Local and Systemic NK Cell Development

Journal of Immunology

Allergy

Immunology

2014

English

ADCC-Mediated CD56dim NK Cell Responses Are Associated With Early HBsAg Clearance in Acute HBV Infection

Pathogens and Immunity

2018

English

The Diagnosis and Management of NK/T-cell Lymphomas

Journal of Hematology and Oncology

English

B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience

Annals of the Rheumatic Diseases

English

Antibody-Targeted Paclitaxel Loaded Nanoparticles for the Treatment of CD20+ B-Cell Lymphoma

Scientific Reports

Multidisciplinary

2017

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bai Liu

The IL-15 Superagonist ALT-803 Enhances Anti-Cd20 Antibody-Directed NK Cell ADCC and in Vivo Clearance of B Cell Lymphomas

Challenge or Opportunity of Climate Financial Fragmentation

Related publications

Combining ROR1- Specific Chimeric Antigen Receptor (CAR) NK Cells With IL-15 Superagonist (N-803/Alt-803) to Target Chemotherapy Resistant Neuroblastoma

Combining Dinutuximab With ALT-803 (IL-15 Superagonist) Significantly Improves the Activity of Ex Vivo Expanded Natural Killer Cells Against GD2 + Pediatric Solid Tumors (ST)

Elotuzumab Directly Enhances NK Cell Cytotoxicity Against Myeloma via CS1 Ligation: Evidence for Augmented NK Cell Function Complementing ADCC

Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models

Adipocyte IL-15 Regulates Local and Systemic NK Cell Development

ADCC-Mediated CD56dim NK Cell Responses Are Associated With Early HBsAg Clearance in Acute HBV Infection

The Diagnosis and Management of NK/T-cell Lymphomas

B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience

Antibody-Targeted Paclitaxel Loaded Nanoparticles for the Treatment of CD20+ B-Cell Lymphoma